5 Results for "

CERK

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CERK" in MCE Product Catalog:

  • Categories Recommended:
    More
3
3 Cited Publications
Cat. No.: HY-13945
CAS No.: 362003-83-6
Purity:  99.73%
Target:  

Apoptosis

Research Areas:  

Cancer

NVP 231 is a potent, specific, and reversible ceramide kinase (CerK) inhibitor(IC50=12 nM) that competitively inhibits binding of ceramide to CerK . NVP 231 induces cell apoptosis by increasing DNA fragmentation and caspase-3 and caspase-9 cleavage .
loading...
    loading...
Cat. No.: HY-RS02534
Research Areas:  

Others

CERK Human Pre-designed siRNA Set A contains three designed siRNAs for CERK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19583
Research Areas:  

Others

Cerk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cerk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26080
Research Areas:  

Others

Cerk Rat Pre-designed siRNA Set A contains three designed siRNAs for Cerk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-12931
CAS No.: 947605-77-8
Target:  

ERK

Research Areas:  

Cancer

ERK2-IN-7 is an ATP-competitive ERK2 inhibitor (mouse IC50 = 0.36 μM (cERK2) and 2.6 μM (aERK2); Kd = 0.05 μM (apo ERK2) and 0.14 μM (pERK2)). ERK2-IN-7 binds both inactive and phosphorylated ERK2 and blocks MEK-mediated ERK1/2 phosphorylation through induced-fit conformational changes of the Gly-rich loop and Tyr34, thereby inhibiting p90RSK phosphorylation and proliferation in BRAF-mutant cancer cells. ERK2-IN-7 can be used for research on melanoma and colon cancer .
loading...
    loading...